Compare Nomura Holdings Inc (NMR) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nomura Holdings Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Nomura Holdings Inc trades at $9.4 (market cap $27.46B), while State Street SPDR S&P Biotech ETF trades at $154.4. The key difference: Nomura Holdings Inc pays a 3.45% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| NMR | XBI | |
|---|---|---|
Market Cap | $27.46B | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $10.04 | $164.28 |
52-Week Low | $6.39 | $85.16 |
Dividend Yield | 3.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
